The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent.
 
Prasad S. Adusumilli
No Relationships to Disclose
 
Marjorie Glass Zauderer
Consulting or Advisory Role - Aldeyra Therapeutics; Epizyme
Research Funding - Bristol-Myers Squibb (Inst); Epizyme (Inst); MedImmune (Inst); Millennium (Inst); Polaris (Inst); Sellas Life Sciences (Inst)
Other Relationship - Mesothelioma Applied Research Foundation
 
Valerie W. Rusch
Research Funding - Genelux (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; da Vinci Surgery
Other Relationship - NIH/Coordinating Center for Clinical Trials
 
Roisin O'Cearbhaill
No Relationships to Disclose
 
Amy Zhu
No Relationships to Disclose
 
Daniel Ngai
No Relationships to Disclose
 
Erin McGee
No Relationships to Disclose
 
Navin Chintala
No Relationships to Disclose
 
John Messinger
No Relationships to Disclose
 
Waseem Cheema
No Relationships to Disclose
 
Elizabeth Halton
No Relationships to Disclose
 
Claudia Diamonte
Travel, Accommodations, Expenses - Juno Therapeutics
 
John Pineda
No Relationships to Disclose
 
Alain Vincent
No Relationships to Disclose
 
Shanu Modi
Speakers' Bureau - Genentech
Research Funding - Daiichi Sankyo; Novartis; Roche/Genentech; Seagen; Synta
 
Stephen Barnett Solomon
Leadership - Aperture Medical
Stock and Other Ownership Interests - Adgero Biopharmaceuticals; Aperture Medical; Aspire Bariatrics; Immunomedics; Impulse; Innoblative Designs; Johnson & Johnson; Motus GI; Progenics
Consulting or Advisory Role - Adgero Biopharmaceuticals; Aperture Medical; BTG; Innoblative Designs; Johnson & Johnson; Medtronic; Xanthus
Research Funding - AngioDynamics (Inst); Elesta (Inst); GE Healthcare (Inst)
Patents, Royalties, Other Intellectual Property - Aperture Medical licensed; Aspire Bariatrics; GE Healthcare-patents pending (Inst)
 
David Randolph Jones
Consulting or Advisory Role - AstraZeneca; Diffusion Pharmaceuticals; Merck
 
Renier J. Brentjens
Stock and Other Ownership Interests - JUNO Therapeutics
Consulting or Advisory Role - JUNO Therapeutics
Research Funding - JUNO Therapeutics
Patents, Royalties, Other Intellectual Property - Scientific Cofounder of JUNO therapeutics
 
Isabelle Riviere
No Relationships to Disclose
 
Michel Sadelain
Consulting or Advisory Role - Juno Therapeutics
Research Funding - Atara Biotherapeutics; Fate Therapeutics; Juno Therapeutics; Takeda; Takeda; Takeda; Takeda
Patents, Royalties, Other Intellectual Property - Licensed patent to Juno Therapeutics.
Other Relationship - Berkeley Lights